State Street’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.05B | Sell |
5,380,821
-1,726
| -0% | -$335K | 0.04% | 376 |
|
|
2025
Q4 | $934M | Buy |
5,382,547
+158,617
| +3% | +$28.9M | 0.03% | 408 |
|
|
2025
Q3 | $996M | Buy |
5,223,930
+38,931
| +0.8% | +$6.91M | 0.03% | 402 |
|
|
2025
Q2 | $931M | Buy |
5,184,999
+8,140
| +0.2% | +$1.41M | 0.03% | 401 |
|
|
2025
Q1 | $876M | Sell |
5,176,859
-44,617
| -0.9% | -$7.33M | 0.04% | 400 |
|
|
2024
Q4 | $788M | Sell |
5,221,476
-41,755
| -0.8% | -$6.49M | 0.03% | 435 |
|
|
2024
Q3 | $817M | Buy |
5,263,231
+70,578
| +1% | +$10.5M | 0.03% | 424 |
|
|
2024
Q2 | $711M | Sell |
5,192,653
-6,541
| -0.1% | -$896K | 0.03% | 437 |
|
|
2024
Q1 | $692M | Sell |
5,199,194
-130,918
| -2% | -$17M | 0.03% | 455 |
|
|
2023
Q4 | $735M | Sell |
5,330,112
-11,293
| -0.2% | -$1.48M | 0.04% | 421 |
|
|
2023
Q3 | $651M | Sell |
5,341,405
-190,365
| -3% | -$25.4M | 0.04% | 420 |
|
|
2023
Q2 | $778M | Sell |
5,531,770
-144,188
| -3% | -$19.9M | 0.04% | 386 |
|
|
2023
Q1 | $803M | Sell |
5,675,958
-182,651
| -3% | -$26.1M | 0.05% | 378 |
|
|
2022
Q4 | $917M | Sell |
5,858,609
-123,888
| -2% | -$17.8M | 0.05% | 343 |
|
|
2022
Q3 | $734M | Sell |
5,982,497
-64,296
| -1% | -$8.47M | 0.05% | 378 |
|
|
2022
Q2 | $804M | Sell |
6,046,793
-83,802
| -1% | -$11.4M | 0.05% | 357 |
|
|
2022
Q1 | $839M | Sell |
6,130,595
-115,124
| -2% | -$16M | 0.04% | 394 |
|
|
2021
Q4 | $1.08B | Buy |
6,245,719
+144,251
| +2% | +$21.9M | 0.05% | 350 |
|
|
2021
Q3 | $887M | Sell |
6,101,468
-107,834
| -2% | -$15.8M | 0.05% | 366 |
|
|
2021
Q2 | $819M | Buy |
6,209,302
+145,692
| +2% | +$19.1M | 0.04% | 394 |
|
|
2021
Q1 | $778M | Sell |
6,063,610
-292,382
| -5% | -$36M | 0.04% | 379 |
|
|
2020
Q4 | $757M | Sell |
6,355,992
-323,354
| -5% | -$39.4M | 0.05% | 370 |
|
|
2020
Q3 | $765M | Buy |
6,679,346
+6,458
| +0.1% | +$763K | 0.05% | 329 |
|
|
2020
Q2 | $760M | Sell |
6,672,888
-145,910
| -2% | -$15.5M | 0.06% | 317 |
|
|
2020
Q1 | $548M | Buy |
6,818,798
+179,263
| +3% | +$18.6M | 0.05% | 341 |
|
|
2019
Q4 | $709M | Buy |
6,639,535
+297,204
| +5% | +$31M | 0.05% | 360 |
|
|
2019
Q3 | $679M | Buy |
6,342,331
+48,167
| +0.8% | +$4.94M | 0.05% | 357 |
|
|
2019
Q2 | $641M | Sell |
6,294,164
-91,456
| -1% | -$8.79M | 0.05% | 368 |
|
|
2019
Q1 | $574M | Buy |
6,385,620
+58,649
| +0.9% | +$5.08M | 0.04% | 390 |
|
|
2018
Q4 | $527M | Buy |
6,326,971
+8,126
| +0.1% | +$762K | 0.05% | 368 |
|
|
2018
Q3 | $682M | Buy |
6,318,845
+148,721
| +2% | +$16.3M | 0.05% | 345 |
|
|
2018
Q2 | $678M | Sell |
6,170,124
-167,259
| -3% | -$17.4M | 0.06% | 327 |
|
|
2018
Q1 | $636M | Sell |
6,337,383
-293,578
| -4% | -$30.1M | 0.05% | 351 |
|
|
2017
Q4 | $653M | Sell |
6,630,961
-109,414
| -2% | -$10.4M | 0.05% | 352 |
|
|
2017
Q3 | $631M | Sell |
6,740,375
-83,848
| -1% | -$8.9M | 0.05% | 346 |
|
|
2017
Q2 | $759M | Sell |
6,824,223
-94,677
| -1% | -$10M | 0.07% | 295 |
|
|
2017
Q1 | $679M | Buy |
6,918,900
+180,690
| +3% | +$17.2M | 0.06% | 321 |
|
|
2016
Q4 | $619M | Buy |
6,738,210
+462,214
| +7% | +$39.8M | 0.06% | 330 |
|
|
2016
Q3 | $531M | Buy |
6,275,996
+194,702
| +3% | +$16.4M | 0.05% | 353 |
|
|
2016
Q2 | $495M | Sell |
6,081,294
-48,554
| -0.8% | -$3.7M | 0.05% | 354 |
|
|
2016
Q1 | $438M | Sell |
6,129,848
-33,973
| -0.6% | -$2.28M | 0.05% | 395 |
|
|
2015
Q4 | $439M | Buy |
6,163,821
+5,878
| +0.1% | +$395K | 0.05% | 381 |
|
|
2015
Q3 | $379M | Sell |
6,157,943
-29,336
| -0.5% | -$2.05M | 0.04% | 411 |
|
|
2015
Q2 | $449M | Sell |
6,187,279
-277,871
| -4% | -$20.5M | 0.05% | 375 |
|
|
2015
Q1 | $497M | Sell |
6,465,150
-241,688
| -4% | -$17.3M | 0.05% | 366 |
|
|
2014
Q4 | $450M | Buy |
6,706,838
+179,859
| +3% | +$11.3M | 0.04% | 399 |
|
|
2014
Q3 | $396M | Buy |
6,526,979
+193,232
| +3% | +$11.9M | 0.04% | 409 |
|
|
2014
Q2 | $372M | Sell |
6,333,747
-34,405
| -0.5% | -$2.01M | 0.04% | 426 |
|
|
2014
Q1 | $369M | Sell |
6,368,152
-192,834
| -3% | -$10.3M | 0.04% | 410 |
|
|
2013
Q4 | $351M | Sell |
6,560,986
-81,635
| -1% | -$4.84M | 0.04% | 429 |
|
|
2013
Q3 | $410M | Sell |
6,642,621
-85,287
| -1% | -$5.1M | 0.05% | 365 |
|
|
2013
Q2 | $408M | Buy |
+6,727,908
| New | +$401M | 0.05% | 355 |
|
Other funds holding DGX
VCM
VPM
EIG
State Street's DGX Position: Q1 2026 in Review
State Street reduced its Quest Diagnostics (DGX) stake by 0.03% in Q1 2026, selling an estimated $335K and leaving 5,380,821 shares worth $1.05B. The position accounts for 0.04% of the portfolio, ranked #376.
State Street first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.08B in Q4 2021. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- State Street held 5,380,821 shares of Quest Diagnostics worth $1.05B as of Q1 2026.
- State Street sold 1,726 Quest Diagnostics shares in Q1 2026, an estimated $335K.
- Quest Diagnostics made up 0.04% of State Street's portfolio in Q1 2026, its #376 holding.
- State Street first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
- State Street's Quest Diagnostics position peaked at $1.08B in Q4 2021.
- 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.